Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain

Summary

To study the 2-year PFS (progression-free survival) of patients with stage II-III nasopharyngeal carcinoma treated with induction chemotherapy followed by two different doses of intensity modulated radiation therapy plus concurrent cisplatin chemotherapy

Timeline

Start

2022-05-11

Primary completion

2026-10-29

Completion

2029-10-29

Drugs

Indications